ASCENEURON SA has a total of 44 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, EPO (European Patent Office) and Republic of Korea. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CROOKS PETER A, SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO LTD and SUZHOU KINTOR PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | EPO (European Patent Office) | 10 | |
#3 | Republic of Korea | 6 | |
#4 | Brazil | 4 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Australia | 2 | |
#7 | China | 2 | |
#8 | Israel | 2 | |
#9 | Canada | 1 | |
#10 | Japan | 1 | |
#11 | Mexico | 1 | |
#12 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Organic chemistry methods | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kulkarni Santosh S | 36 |
#2 | Quattropani Anna | 36 |
#3 | Giri Awadut Gajendra | 31 |
#4 | Anna Quattropani | 6 |
#5 | Awadut Gajendra Giri | 6 |
#6 | Santosh S Kulkarni | 6 |
#7 | Murugesan Kathiravan | 4 |
#8 | Toronto Dawn V | 4 |
#9 | Banerjee Joydeep | 4 |
#10 | Crowe David Malcolm | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020169804A1 | Fused glycosidase inhibitors | |
US2021077488A1 | Linear glycosidase inhibitors | |
KR20180132060A | Acid addition salts of piperazine derivatives | |
US2019062316A1 | Process for the separation of enantiomers of piperazine derivatives | |
US2017298082A1 | Glycosidase inhibitors | |
EP2813505A1 | Tetraaza-cyclopenta[a]indenyl derivatives |